Vantage Consulting Group Inc ADCT Holdings History
Number of Shares
850,737.00
Current Holdings Value*
$1.20 Mil
% of Portfolio
23.88%
Total Estimate Gain
$-46.96 Mil
% of Total Estimate Gain
-85.27%
Vantage Consulting Group Inc's ADC Therapeutics SA Holding Summary
As of 2025-03-31, Vantage Consulting Group Inc held 850,737.00 shares of ADC Therapeutics SA(ADCT), totaling $1.20 Mil. This investment constitutes 23.88% of their stock portfolio, and Vantage Consulting Group Inc now holds 0.86% of the outstanding ADC Therapeutics SA(ADCT) stock.
The initial trade took place in 2020Q4. In addition, there have been 3 sales at an average price of $6.55 for 829,412.00 shares. Based on historical transaction data and ADCT's current price of $3.15, Vantage Consulting Group Inc's estimated gain on his ADCT holdings is $-46.96 Mil, reflecting a -85.27% gain to date.
Vantage Consulting Group Inc ADCT ($3.15) Holding Chart
Vantage Consulting Group Inc ADCT ($3.15) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1